November 2023

Salix, seeking to tackle stigma, co-creates awareness day for opioid-induced constipation

Salix, seeking to tackle stigma, co-creates awareness day for opioid-induced constipation

Salix Pharmaceuticals is putting a new date in the disease awareness calendar. Working with two nonprofits, the drugmaker has declared Dec. 5 Opioid-Induced Constipation (OIC) Awareness Day to try to tackle the stigma and silence surrounding this condition. According to Salix and the two nonprofits, the U.S. Pain Foundation and the International Foundation for Gastrointestinal […]

Salix, seeking to tackle stigma, co-creates awareness day for opioid-induced constipation Read More »

Endo brings men to the pool hall for straight talk on Peyronie’s in latest Xiaflex push

Endo brings men to the pool hall for straight talk on Peyronie’s in latest Xiaflex push

Endo is taking its Peyronie’s disease campaign from the vegetable aisle to the pool hall. Having initially relied on wonky veg to discuss the men’s health condition, the drugmaker has now brought four people with Peyronie’s together to shoot some pool and chat about their experiences. Across three videos, the men, who range in age

Endo brings men to the pool hall for straight talk on Peyronie’s in latest Xiaflex push Read More »

Pfizer site in Connecticut in line for layoffs amid $3.5B cost-cutting campaign

Pfizer site in Connecticut in line for layoffs amid $3.5B cost-cutting campaign

With layoffs hitting employees on both sides of the Atlantic, Pfizer’s $3.5 billion cost-cutting spree has kicked it into high gear this month. Now, the company’s Groton, Connecticut, site is the latest to face cuts. It’s unclear how many positions will be affected at the research site, which currently employs over 2,600 people, but the

Pfizer site in Connecticut in line for layoffs amid $3.5B cost-cutting campaign Read More »

Dr. Reddy’s scolded for maintenance shortfalls in new FDA Form 483 filing

Dr. Reddy’s scolded for maintenance shortfalls in new FDA Form 483 filing

It’s critical to keep your workplace equipment clean and calibrated—especially in the realm of pharmaceutical manufacturing. Now, Dr. Reddy’s failure to uphold those standards has landed the Indian drugmaker in hot water with the U.S. FDA, according to one of two new Forms 483 posted on the regulator’s website this week. In a 10-observation write-up,

Dr. Reddy’s scolded for maintenance shortfalls in new FDA Form 483 filing Read More »

Fighting unauthorized GLP-1 knockoffs, Novo Nordisk files 2 new lawsuits against Florida companies

Fighting unauthorized GLP-1 knockoffs, Novo Nordisk files 2 new lawsuits against Florida companies

Seven weeks after a federal judge dismissed (PDF) a Novo Nordisk’s lawsuit, which accused a Florida pharmacy of selling unauthorized knockoffs of its GLP-1 drugs Wegovy, Ozempic and Rybelsus, Novo has sued the same company. Brooksville Pharmaceuticals is the target of a refiled Novo lawsuit, this one claiming there are impurities in the company’s compounded

Fighting unauthorized GLP-1 knockoffs, Novo Nordisk files 2 new lawsuits against Florida companies Read More »

AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field

AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field

The sizzling antibody-drug conjugate (ADC) field is at the center of another major life sciences deal.  This time, AbbVie is shelling out $10.1 billion in cash to acquire ImmunoGen, maker of the ovarian cancer treatment Elahere, which won FDA accelerated approval about a year ago. The acquisition accelerates AbbVie’s entry into the solid tumor space

AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field Read More »

Study finds ways to direct medications to particular body parts – ET HealthWorld

Study finds ways to direct medications to particular body parts – ET HealthWorld

Gothenburg: A study conducted by academics at the University of Gothenburg revealed a method that can change the way medicines are delivered to specific parts of the body. Until the temperature climbs over 32 degrees, microgels create a thin protective shell around a droplet. The microgels then contract and the droplet dissolves in the surrounding

Study finds ways to direct medications to particular body parts – ET HealthWorld Read More »

It’s important to invest in latest security strategies for pre-emptive action rather than course-correction later – Express Healthcare

It’s important to invest in latest security strategies for pre-emptive action rather than course-correction later – Express Healthcare

It’s important to invest in latest security strategies for pre-emptive action rather than course-correction later – Express Healthcare Home News It’s important to invest in latest security strategies for pre-emptive action rather than course-correction later You cannot print contents of this website. Source link

It’s important to invest in latest security strategies for pre-emptive action rather than course-correction later – Express Healthcare Read More »

SMART and CAMP collaborate to develop safer T-cell therapies

SMART and CAMP collaborate to develop safer T-cell therapies

The new method successfully performs sterility assessments within 24 hours Researchers from the Singapore-MIT Alliance for Research and Technology’s (SMART) Critical Analytics for Manufacturing Personalized-Medicine (CAMP) Interdisciplinary Research Group have collaborated to develop safer T-cell therapies. In partnership with the Singapore Centre for Environmental Life Sciences Engineering and the Massachusetts Institute of

SMART and CAMP collaborate to develop safer T-cell therapies Read More »

Scroll to Top